Journal of Modern Oncology
ISSN 1815-1434 (Print)
ISSN 1815-1442 (Online)
Menu
Archives
Home
About the Journal
Editorial Policies
Author Guidelines
About the Journal
Issues
Search
Current
Archives
Contact
Editorial board
OmniDoctor
All Journals
User
Username
Password
Remember me
Forgot password?
Register
Search
Search
Search Scope
All
Authors
Title
Abstract
Index terms
Full Text
Browse
By Issue
By Author
By Title
Other Journals
×
User
Username
Password
Remember me
Forgot password?
Register
Search
Search
Search Scope
All
Authors
Title
Abstract
Index terms
Full Text
Browse
By Issue
By Author
By Title
Other Journals
Home
>
Search
>
Author Details
Author Details
Kaplanov, Kamil D.
Issue
Section
Title
File
Vol 21, No 4 (2019)
CLINICAL ONCOLOGY
The role of second generation Bruton tyrosine kinase inhibitors in the treatment of chronic lymphocytic leukemia. Resolution
(Rus)
Vol 22, No 1 (2020)
CLINICAL ONCOLOGY
ELEVATE-TN Study. New data of acalabrutinib in first-line treatment of chronic lymphocytic leukemia. Resolution
(Rus)
Vol 22, No 2 (2020)
Conference Proceedings
New opportunities of systemic therapy of CD30-positive primary cutaneous T-cell lymphomas
(Rus)
Vol 23, No 1 (2021)
CLINICAL ONCOLOGY
Modern approaches in the first line treatment of CD30-positive peripheral T-cell lymphomas
(Rus)
Vol 23, No 2 (2021)
CLINICAL ONCOLOGY
The Russian Expert Council on the application of new highly selective inhibitor of Bruton’s tyrosine kinase zanubrutinib in the treatment of patients with relapsed/refractory mantle cell lymphoma. Event review
(Rus)
Vol 23, No 3 (2021)
CLINICAL ONCOLOGY
ELEVATE-RR – first head-to-head trial of acalabrutinib versus ibrutinib in previously treated high risk chronic lymphocytic leukemia
(Rus)
This website uses cookies
You consent to our cookies if you continue to use our website.
About Cookies
TOP